Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral contraceptives.

Edith Weisberg1

  • 1Department of Obstetrics and Gynaecology, University of Sydney, New South Wales. edithweisberg@bigpond.com

Australian Family Physician
|October 31, 2002
PubMed
Summary

Choosing combined oral contraceptives (COCs) requires careful consideration of individual health factors. General practitioners can use guidelines to select appropriate COC formulations, especially for women with specific conditions or risk factors for venous thromboembolism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation.

Contraception·2019
Same author

Contraception and endometriosis: challenges, efficacy, and therapeutic importance.

Open access journal of contraception·2018
Same author

Age differences in attitudes toward safer sex practices in heterosexual men using an Australian Internet dating service.

Sexual health·2017
Same author

Contraception - what about the men? Experience, knowledge and attitudes: a survey of 2438 heterosexual men using an online dating service.

Sexual health·2017
Same author

Potentially effective therapy of heavy menstrual bleeding with an oestradiol-nomegestrol acetate oral contraceptive: a pilot study.

Pilot and feasibility studies·2017
Same author

A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population.

Contraception·2016

Area of Science:

  • Pharmacology and Therapeutics
  • Women's Health
  • General Practice

Background:

  • Numerous combined oral contraceptive (COC) formulations exist in Australia, varying in ethinylestradiol and progestogen content.
  • Clinical effects may differ between COC formulations, with new preparations continually entering the market.

Purpose of the Study:

  • To provide general practitioners (GPs) with guidelines for prescribing COCs.
  • To assist GPs in selecting appropriate COCs for women with diverse clinical conditions and needs.

Main Methods:

  • Guideline development for COC prescribing.
  • Consideration of clinical conditions and patient needs.
  • Risk assessment for side effects like venous thromboembolism.

Main Results:

  • Low-dose COCs are suitable for most healthy women.
  • Specific patient groups, including those with epilepsy or other risk factors, require careful prescribing.
  • Venous thromboembolism is the most common serious side effect, with risks influenced by age, obesity, smoking, and medical conditions.

Conclusions:

  • Women with risk factors need careful consideration and counseling regarding progestogen risks.
  • Shared decision-making is crucial for selecting COCs, particularly for women with increased venous thromboembolism risk.
  • Guidelines assist GPs in optimizing COC selection for individual patient profiles.

Related Experiment Videos